In vivo genetic screens in PD-1 resistant mouse models identified modulators of anti-PD1 response with relevance to pembrolizumab-treated human metastatic melanoma
Journal article published in 2019 by
Aurelie Docquier,
Cecile Dejou,
Gilles Alberici,
Armand Bensussan,
Jeremy Bastid,
Nathalie Bonnefoy 
